Approval · Notice of Compliance 36925 · 2026
TEPADINA: Notice of Compliance 36925
Issued February 17, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36925
- Date
- February 17, 2026
- Company
- Adienne SaLugano, Tessin, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Fulfillment of commitment(s) [Confirmatory Study ADN013] of the LOU dated (March 16-2017), issued under (S)NDS control # [168816]. Update to the Product Monograph with new safety and efficacy information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEPADINA | Not yet assigned | — |